Investigation Launched into Selectis Health, Inc. by Class Action Firm Over Sale to Black Pearl Equities

Shareholder Alert: Investigation into Selectis Health, Inc.

In a significant development for shareholders, Monteverde & Associates PC, often referred to as the M&A Class Action Firm, has announced a formal investigation into Selectis Health, Inc. This inquiry comes on the heels of Selectis Health's decision to sell itself to Black Pearl Equities II, LLC. Under the terms of this proposed transaction, shareholders of Selectis Health are set to receive $5.75 per share in cash, prompting questions about the fairness of this offer.

Juan Monteverde, a prominent class action attorney and head of the firm, has built a reputation for successfully recovering substantial amounts for investors in previous class action lawsuits. In the 2025 ISS Securities Class Action Services Report, Monteverde & Associates was recognized among the Top 50 firms, underscoring their effectiveness and dedication to shareholder rights.

This investigation marks a pivotal moment for those invested in Selectis Health as it aims to discern whether the proposed sale is equitable for shareholders. Questions are now being raised about the valuation of Selectis Health and whether receiving $5.75 per share truly reflects its market potential and future prospects.

As part of their investigation, Monteverde & Associates PC encourages shareholders to consider their positions. Investors are advised to ask crucial questions when approaching a law firm regarding potential class actions:

- Does your firm handle class actions and appear in court?
- When was the last recovery made for shareholders by your firm?
- What specific cases have led to recoveries, and what were the outcomes?

The firm operates from its offices in the iconic Empire State Building in New York City, which is emblematic of its stature and commitment to the field of securities law. The extensive experience of Monteverde & Associates in handling class action lawsuits has proven beneficial to many shareholders across diverse cases in the past.

For those holding common stock in Selectis Health and looking for additional information, Monteverde & Associates offers consultation at no cost. Interested shareholders can visit their website or reach out directly to Juan Monteverde at the firm via email or phone for queries.

While specific details of the investigation and future actions taken by the firm remain forthcoming, this active inquiry emphasizes the firm’s proactive approach to defending shareholder interests, particularly in situations where company sales may impact stock values.

In a marketplace rife with uncertainties, this investigation serves as a reminder of the vital checks and balances in corporate transactions. Shareholders are urged to stay informed and engaged with the developments regarding Selectis Health, making sure they assess the situation critically and seek the necessary advice to protect their investments.

As the inquiry progresses, all eyes will remain on the unfolding events surrounding Selectis Health's sale to Black Pearl Equities, particularly as Monteverde & Associates aims to ensure that shareholder rights are upheld throughout this process. Investors with concerns are encouraged to remain vigilant and consider their options carefully, especially as the date of the proposed transaction approaches.